Skip to main content
THERACRYF PLC logo

THERACRYF PLC — Investor Relations & Filings

Ticker · TCF ISIN · GB00BSVYN304 LEI · 213800NO3E6TSTQO8K20 IL Professional, scientific and technical activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2020-12-23 Regulatory Filings
Country GB United Kingdom
Listing IL TCF

About THERACRYF PLC

https://theracryf.com/

TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 100% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Second Price Monitoring Extension' for Evgen Pharma PLC. It is a standard market regulatory announcement concerning trading mechanics rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2020-12-23 English
Price Monitoring Extension
Regulatory Filings Classification · 100% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Price Monitoring Extension' for Evgen Pharma PLC. It does not contain financial results, board changes, or other specific corporate reports. As it is a general regulatory announcement regarding trading parameters that does not fit into the specific categories provided, it is classified as a Regulatory Filing (RNS).
2020-12-23 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half year Report' for Evgen Pharma plc for the six months ended 30 September 2020. It contains detailed operational highlights, financial highlights, a Chairman's and Chief Executive's statement, and a financial review. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2020
2020-12-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' for Evgen Pharma PLC. This form is used to notify the issuer and the regulator when a shareholder's interest crosses a specific threshold (in this case, 3.074%). This falls directly under the definition of a Major Shareholding Notification.
2020-11-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This specific document type is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-11-27 English
Recruitment of first patient in STAR trial
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the Regulatory News Service (RNS) regarding a clinical trial milestone (recruitment of the first patient in the STAR trial). It does not fit into specific categories like financial reports, dividend announcements, or director dealings. As it is a general corporate announcement regarding operational progress, it falls under the 'Regulatory Filings' (RNS) category.
2020-11-23 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.